Cheapest GLP-1 Providers in 2026

Summary: The cheapest legitimate GLP-1 in 2026 is brand Zepbound or Wegovy through manufacturer self-pay portals at $199 to $499 a month, with telehealth programs filling the gap for patients who want clinician support bundled in.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The cheapest legitimate GLP-1 in 2026 is brand Zepbound through LillyDirect at $349 a month for a 2.5 mg single-dose vial, or brand Wegovy through NovoCare Pharmacy at $199 a month for the starter dose [1][2]. Below that, the only options are insurance-covered prescriptions for diabetes, legitimate telehealth bundles in the $99 to $249 range, or compounded vials, which are now a much thinner market than they were eighteen months ago.

This page ranks every real pathway by what you actually pay at the maintenance dose, not the bait price. It calls out the providers worth your time and the ones not worth the trade-off.

The 2026 price hierarchy, ranked

Real all-in pricing for a person at maintenance dose (5 mg tirzepatide or 1.7 to 2.4 mg semaglutide), not a one-month promo.

PathwayMonthly costWhat you get
Insurance-covered Wegovy or Zepbound$0 to $25Brand drug with savings card and coverage
Insurance-covered Mounjaro or Ozempic (T2D)$0 to $25Brand drug, on-label diabetes diagnosis required
NovoCare Wegovy self-pay starter$199 (first month $499 then savings)Brand semaglutide, all doses
LillyDirect Zepbound 2.5 mg vial$349Brand tirzepatide vial, lowest brand tirzepatide
LillyDirect Zepbound 5 mg vial$499Brand tirzepatide vial, maintenance dose
LillyDirect Zepbound 7.5 to 15 mg vial$599Brand tirzepatide vial, higher doses
NovoCare Wegovy any dose pen$499Brand semaglutide pen, all doses self-pay
Telehealth compounded program$99 to $249Compounded peptide plus clinician visit
Brand pens through telehealth$349 to $499Same drug as direct, with added service fee
Cash brand at retail pharmacy$1,060 to $1,350Full sticker, no negotiation

If a provider is quoting you a number that beats the first row of this table, ask what is missing. There is almost always a missing piece. Lab work, shipping, a separate consult fee, a higher second-month price, a starter dose only, or a compounded product whose supply chain you should look into.

How the 2026 market got reshaped

The compounded GLP-1 boom that defined 2023 to 2025 is over. The FDA declared the semaglutide and tirzepatide shortages resolved in 2025, which closed the legal window that 503A and 503B pharmacies had used to produce copies of Wegovy and Zepbound in bulk [3]. Several large compounding operations, including ProRx and BPI Labs, stopped producing tirzepatide in early 2026 after a public comment period that ran through June 29, 2026.

Compounded GLP-1 still exists. It is now sold under narrower legal carve-outs, primarily personalized dosing claims like microdose strengths or combination products that include B12 or other peptides. The aggressive $99 a month compounded tirzepatide that flooded telehealth in 2024 is no longer the headline of the market. The headline now belongs to the manufacturers, who responded to the loss of compounded competition by cutting their own self-pay prices dramatically.

That shift created the ranking above. Brand Zepbound at $349 for a starter vial was not a real number in 2024. It is a real number in 2026 because Lilly built LillyDirect, ships from its own pharmacy, and pulled the middleman out of the cost stack.

LillyDirect Self-Pay: cheapest brand tirzepatide path

Eli Lilly sells Zepbound directly through LillyDirect Pharmacy in single-dose vials at these prices [1]:

Vial strengthLillyDirect Self-Pay priceNotes
2.5 mg$349/month4 vials per month, starter dose
5 mg$499/month4 vials per month, common maintenance
7.5 mg$599/month4 vials per month
10 mg$599/month4 vials per month
12.5 mg$599/month4 vials per month
15 mg$599/month4 vials per month, top maintenance

The vials are FDA-approved Zepbound, manufactured by Lilly, dispensed by a Lilly-owned pharmacy. You need a prescription, which means a telehealth or in-person clinician visit, but the medication itself is brand tirzepatide at the lowest cash price the market has seen.

The Zepbound pen autoinjectors, which most pharmacies still stock, run at the standard retail $1,060 a month without insurance. The vials cost less because they require a syringe and a small amount of patient self-administration knowledge. The drug inside is identical.

NovoCare Self-Pay: cheapest brand semaglutide path

Novo Nordisk runs the equivalent program through NovoCare Pharmacy for Wegovy and Ozempic [2]. The structure is slightly different from Lilly's:

  • Wegovy starter month (0.25 mg): $199 with the savings offer
  • Wegovy ongoing doses through NovoCare Pharmacy: $499/month for any dose pen
  • Oral Wegovy (semaglutide tablet): $149/month for 1.5 mg, $149 through April 15, 2026 then $199 for 4 mg
  • Ozempic self-pay: $499/month for any dose pen

The $199 starter price is real but it only applies to the 0.25 mg titration dose for the first month. Once you escalate, the price moves to $499 unless you are on the oral tablet. Oral Wegovy at $149 a month is the cheapest brand-name GLP-1 cash price available in 2026, full stop. It is a tablet, not an injection, and dosing logistics are different, but for patients who want brand-name semaglutide and want to avoid needles entirely, it is the lowest published number.

If you are diabetic and your insurance covers Ozempic, the NovoCare cash price is irrelevant. Your copay will beat it. If you are not diabetic and want brand semaglutide for weight loss, NovoCare Wegovy is the cleanest path.

Legitimate telehealth: $99 to $249 a month tier

A handful of telehealth providers still ship legal GLP-1 prescriptions at sub-$250 monthly all-in pricing. The model has shifted: compounded inventory is harder to source, so providers have either narrowed their compounded SKUs, moved to oral compounded or combination products, or transitioned to facilitating brand prescriptions and billing a service membership.

Names that consistently appear in independent 2026 provider rankings [4][5]:

  • Ro Body: $149 to $249 a month. Includes at-home metabolic lab panels and prescription support. Will help with insurance prior authorization. Does Ro accept insurance? Yes, the program coordinates with your benefits for brand Wegovy or Zepbound, though the membership fee is separate from the drug cost.
  • Hims and Hers: $149 to $325 a month for compounded semaglutide programs, $299 to $1,999 for brand options. Discreet and fast, lighter on clinical follow-up.
  • PlushCare GLP-1: $199 to $650 depending on whether you want compounded or brand. Includes a low-cost membership that covers other primary care visits.
  • Push Health GLP-1: Direct-pay prescription model. Clinician visit fee plus prescription routed to a partner pharmacy. Pricing varies by state and the pharmacy that fills.
  • WeightWatchers GLP-1: Roughly $99 per month for the clinical program; medication cost is separate and typically routed through insurance or a partner pharmacy.
  • Mochi Health: Compounded oral and injectable semaglutide, $79 to $199 a month depending on dose and inventory.
  • Found weight loss cost: $99 starting membership, with prescription cost layered on top. Insurance handling is included.
  • Fridays weight loss cost: Roughly $1,498 to $1,828 for a 12-month bundle of compounded options, or insurance-coordinated pricing.
  • Shed weight loss cost: Compounded programs in the $200 to $300 range with shipping included.

The thing every one of these has in common: the headline number is the program fee, not necessarily the full drug cost. Read the second-month and third-month prices before you commit. The cheap first month is often subsidized to get you in the door, and a $79 onboarding offer can become $199 to $300 by week six.

Insurance-covered T2D pathway: the $0 to $25 ceiling

The cheapest GLP-1 in 2026 is still a covered prescription for type 2 diabetes. If you have a documented T2D diagnosis (HbA1c above 6.5 percent, or fasting glucose above 126 mg/dL on two readings), most commercial plans cover Mounjaro, Ozempic, Trulicity, and Victoza on tier 2 or 3, and the manufacturer savings cards can knock the copay to $25 or below for commercially insured patients.

The catch: Medicare and Medicaid plans typically do not accept manufacturer savings cards. If you are on Medicare, the GLP-1 you can access for T2D depends entirely on your Part D formulary. TrumpRx.gov, the federal direct-purchase platform that launched in February 2026, lists Wegovy and Ozempic at most-favored-nation pricing of about $350 a month average, with starter doses as low as $199. A $50/month Medicare GLP-1 program through TrumpRx is announced for mid-2026 but not yet live as of this writing.

For weight loss without diabetes, insurance coverage is much spottier. Wegovy and Zepbound require prior authorization, often a documented BMI above 30 (or above 27 with a comorbidity), and frequently a 6-month documented weight management attempt. If your plan covers either drug under those terms, plus a savings card, your monthly cost can land at $0 to $25.

The compounded reality after the shortage ended

What is left of the compounded market in 2026 is narrower and more legally fragile than it was during the shortage years. The FDA's position is that 503A pharmacies may compound a drug only when the medical need cannot be met by an FDA-approved drug, or when an approved product is unavailable due to drug shortages [3]. Tirzepatide and semaglutide are no longer on the shortage list.

The remaining compounded paths fall into a few buckets:

  • Personalized dosing claims: Providers prescribe a compounded peptide at a non-standard concentration (microdose, oral, sublingual) that the manufacturer does not produce, arguing the personalization is medically necessary for that specific patient.
  • Combination products: Compounded semaglutide or tirzepatide mixed with B12, glycine, or other ingredients in a single vial. This is also defended on personalization grounds.
  • Compounded liraglutide: The first GLP-1 to lose patent exclusivity in 2024. Generic and compounded liraglutide is broadly legal. It is a daily injection rather than weekly and produces less weight loss than semaglutide or tirzepatide, but it is the cheapest legal compounded GLP-1 at roughly $99 to $150 a month.

If you are evaluating a compounded program, ask three questions before you pay. Which 503A or 503B pharmacy fills the prescription? Will they provide a Certificate of Analysis for the batch? What changed in their supply chain after the shortage ended? A provider that cannot answer all three is selling you risk you cannot price.

Decision tree: pick your pathway

The cheapest GLP-1 for you depends on three things: your insurance situation, your diabetes status, and your willingness to do self-administration with vials.

Hidden cost categories most price comparisons skip

The published monthly price almost never captures everything. Real cost in 2026 includes:

  • Initial consult fee: $0 (bundled) to $99 (Push Health, Plush) to $250 (in-person clinic).
  • Lab work: A baseline metabolic panel, HbA1c, and lipid panel are standard before starting. Ro Body and Defy Medical include them; most budget telehealth providers do not. Out of pocket this is $100 to $300.
  • Syringes and sharps disposal: If you are on LillyDirect vials, a box of 100 U-100 insulin syringes is $20 to $30. Pen users avoid this.
  • Anti-nausea support: Ondansetron or other PRN medications for the GI side effects of titration. Usually $10 to $30 if your insurance does not cover it.
  • Shipping: Most telehealth programs include cold-chain overnight shipping. Direct purchase from LillyDirect and NovoCare is the same.
  • Dose escalation premium: Compounded prices often increase at each dose step. A $99 starter price can be a $179 maintenance price.

A program at $99 a month with $250 in bundled fees and $100 in unbundled labs is functionally a $158 a month program for the first year. Always ask what the all-in twelve-month spend looks like before you sign.

Why "cheapest" is not always the right framework

A $99 a month compounded semaglutide from a pharmacy you cannot verify is more expensive than a $349 LillyDirect Zepbound vial if the cheaper option ends up causing a dosing error, a contamination issue, or a year of weight regain because the active ingredient was underconcentrated. The math that matters is not the monthly price. It is the monthly price divided by the probability the medication does what you think it does.

That probability is highest for brand drugs from licensed pharmacies, lower for compounded drugs from accredited 503B outsourcing facilities, and lowest for compounded products from 503A pharmacies that will not share documentation. Price the risk into the comparison and the ranking changes.

For most people in 2026, the right ranking is: insurance-covered brand first, manufacturer self-pay second, established telehealth (with clinician oversight) third, and verified compounded fourth, only when the first three are not accessible.

Common questions about the cheapest GLP-1 providers

What is the absolute cheapest GLP-1 medication in 2026?
Insurance-covered Wegovy or Zepbound with a manufacturer savings card runs $0 to $25 a month. Without insurance, oral Wegovy at $149 through NovoCare is the lowest brand-name price.
What is the cheapest brand-name injectable GLP-1 without insurance?
LillyDirect Zepbound single-dose vials at $349 for 2.5 mg starter and $499 to $599 for maintenance doses. NovoCare Wegovy pen at $499 for any dose.
Is compounded semaglutide still legal in 2026?
Yes, but more narrowly than during the 2023 to 2025 shortage. 503A pharmacies can still compound under personalized dosing or combination product rules. Tirzepatide compounding has been substantially restricted.
Does Ro accept insurance for weight loss?
Yes. Ro Body coordinates with commercial insurance for brand Wegovy or Zepbound, including prior authorization support, while charging a separate program membership fee of $149 to $249 a month.
What is the cost of GLP-1 pills full price?
Oral Wegovy (semaglutide tablet) is $149 a month for 1.5 mg and $199 a month for 4 mg through NovoCare. Rybelsus retail without insurance is roughly $1,000 a month.
Are there over-the-counter GLP-1 options?
No legitimate GLP-1 receptor agonist is sold over the counter in the United States. Products marketed as "GLP-1 gummies," "GLP-1 boosters," or "natural GLP-1" do not contain semaglutide, tirzepatide, or any FDA-approved GLP-1 medication. They are supplements, not GLP-1 drugs.
What is the GLP-1 price per month through TrumpRx full cost?
TrumpRx.gov launched in February 2026 with Wegovy and Ozempic at most-favored-nation pricing averaging $350 a month, with selected starter doses as low as $199. Total cost includes a separate clinician visit and any pharmacy dispensing fees.
How much does WeightWatchers GLP-1 cost?
WeightWatchers Clinic is roughly $99 a month for the clinical program. Medication cost is separate. They route prescriptions through insurance when possible or compounded pharmacy partners when not.
What is the PlushCare GLP-1 cost?
PlushCare is $199 to $650 a month depending on whether you take compounded semaglutide or brand-name Wegovy/Zepbound/Mounjaro/Ozempic. A low-cost membership fee covers other primary care visits within the same program.
What does Push Health GLP-1 cost?
Push Health uses a direct-pay clinician visit model. A telehealth consult is roughly $75 to $150, and the prescription cost depends on which partner pharmacy fills it, typically $150 to $400 a month for compounded semaglutide.
What is the Found weight loss cost?
Found's membership starts around $99 a month, with medication cost layered on top. They coordinate insurance benefits, so total cost depends heavily on your plan.
What is the Fridays weight loss cost?
Fridays bundles a 12-month program for roughly $1,498 to $1,828 ($125 to $152 per month) for compounded semaglutide or tirzepatide options. Insurance-coordinated pricing varies by plan.
What is the Shed weight loss cost?
Shed offers compounded GLP-1 programs in the $200 to $300 a month range, with consults and shipping bundled in.
Is oral GLP-1 for weight loss cheaper than injectable?
Oral Wegovy (semaglutide tablet) at $149 a month through NovoCare is the cheapest brand-name GLP-1 in 2026. Oral options are not always cheaper than injectables historically, but Novo's aggressive pricing on the oral 1.5 mg tablet flipped that script.
What is the cheapest path if I qualify for type 2 diabetes coverage?
A T2D diagnosis qualifies you for insurance coverage of Mounjaro, Ozempic, Trulicity, or Victoza on most commercial plans. Stacked with a manufacturer savings card, the copay typically lands at $25 or less per month.

What this article does not cover

This is a price and access guide for 2026. Side effects, dosing schedules, weight loss expectations, and the comparison between semaglutide and tirzepatide as drugs have their own dedicated pages on this site. Prices change, sometimes monthly. Verify the LillyDirect and NovoCare numbers directly on the manufacturer pages before you commit to a pathway. The structure of the market (manufacturer self-pay leading, compounded retreating, insurance-with-savings-card winning when available) is the part that holds up.

References

  1. Eli Lilly LillyDirect Zepbound self-pay pharmacy pricing
  2. Novo Nordisk NovoCare Wegovy and Ozempic self-pay program
  3. FDA tirzepatide shortage resolution and 503A compounding guidance
  4. Forbes Health, Best Affordable Online GLP-1 Providers 2026
  5. U.S. News, Top GLP-1 Weight Loss Medication Providers 2026